BIOGEN INC (BIIB) Stock Analyst Ratings
NASDAQ:BIIB - Nasdaq - US09062X1037 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 75% to BIIB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 202.08. This target is 43.69% above the current price.
BIIB was analyzed by 42 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about BIIB.
In the previous month the buy percentage consensus was at a similar level.
BIIB was analyzed by 42 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-18 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2025-02-13 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-13 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-02-13 | Needham | Reiterate | Hold -> Hold |
| 2025-02-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-13 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-13 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-13 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-02-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-28 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-01-02 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-12-20 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2024-12-10 | B of A Securities | Reiterate | Neutral |
| 2024-12-09 | Jefferies | Downgrade | Buy -> Hold |
| 2024-11-21 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-11-18 | Needham | Downgrade | Buy -> Hold |
| 2024-11-15 | Wolfe Research | Initiate | Peer Perform |
| 2024-11-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-14 | Citigroup | Initiate | Neutral |
| 2024-11-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-10-31 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-31 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-31 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |